We preliminarily evaluated the distribution of fasting circulating IL32 in the Liver-Bible-2021 cohort of apparently healthy middle-aged individuals with metabolic dysfunction, about two thirds of whom were affected by arterial hypertension. This evidence concerns the gene IL32 and Hypertension.